Thoracic Endovascular Aortic Repair for Aortobronchial Fistula

Canaud, Ludovic; Ozdemir, Baris Ata; Bahia, Sandeep S.; Hinchliffe, Robert J.; Loftus, Ian; Thompson, Matt

doi:10.1016/j.athoracsur.2013.04.090

Cited by 41 publications

(62 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…122 In every case, patients should receive intensive medical and nutritional support to get them into a better general condition before being referred for open surgery. 123…”

Section: Class Level Referencesmentioning

confidence: 99%

“…Open ABF operative mortality ranged from 15% to 41%. 123,128 Open surgical treatment remains the first choice for patients fit for surgery as the EuREC registry showed that a radical surgical approach resulted in significantly better survival (63% at two years) compared with any other treatment strategy. 98 To decrease the risk of ABF recurrence and re-infection, the bronchial defect needs to be repaired surgically.…”

Section: Open Surgical Treatmentmentioning

confidence: 99%

“…After bronchus repair, the EG should be covered with a muscle or pleural flap. 99,123 Sometimes APF can be treated successfully in a more conservative manner by implantation of an EG to control the bleeding, followed by conservative treatment with antimicrobial agents. For persistent infection or recurrent of EG infection, pulmonary resection is indicated.…”

Section: Open Surgical Treatmentmentioning

confidence: 99%

“…For persistent infection or recurrent of EG infection, pulmonary resection is indicated. 123 It is not clear whether the EG always needs to be removed to definitely treat an ABF. 129 In patients fit for surgery, EG removal and in situ vascular repair should be considered.…”

Section: Open Surgical Treatmentmentioning

confidence: 99%

See 3 more Smart Citations

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections

Chakfé

Diener

Lejay

et al. 2020

European Journal of Vascular and Endovascular Surgery

340

322

View full text Add to dashboard Cite

DEDICATIONAfter studying medicine at Hanover Medical School and philosophy and social psychology at the Leibniz University Hanover, Omke E. Teebken joined the Christian Albrechts University in Kiel at the end of the 1990s as a research fellow at the Clinic for Cardiovascular Surgery headed by Professor Dr Axel Haverich, whom Omke E. Teebken later followed back to Hanover.In Hanover, besides working as a clinician, Omke E.Teebken was particularly active scientifically, contributing to the establishment of the then newly founded Leibniz Laboratories for Biotechnology and Artificial Organs (LEBAO). His work focused on regenerative medicine and tissue engineering, and subsequently he wrote his habilitation thesis in in this field. After basic training in cardiac surgery, he specialised clinically in vascular surgery and played a pioneering role in the development of this field. Before being appointed director of the Clinic for Vascular Surgery e Endovascular Surgery at the Peine Clinic in 2016, Omke E. Teebken headed the Vascular Surgery e Endovascular Surgery Division of the Department of Cardiothoracic, Thoracic, Transplantation and Vascular Surgery at Hanover Medical School. Professor Teebken was a highly appreciated, committed, and competent colleague and teacher.On 8 April 2019, Professor Teebken passed away after a short and severe illness. He was member and author of the ESVS guideline writing committee, an esteemed colleague, and friend.We will always honor his memory.

show abstract

“…122 In every case, patients should receive intensive medical and nutritional support to get them into a better general condition before being referred for open surgery. 123…”

Section: Class Level Referencesmentioning

confidence: 99%

Section: Open Surgical Treatmentmentioning

confidence: 99%

Section: Open Surgical Treatmentmentioning

confidence: 99%

Section: Open Surgical Treatmentmentioning

confidence: 99%

See 2 more Smart Citations

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections

Chakfé

Diener

Lejay

et al. 2020

European Journal of Vascular and Endovascular Surgery

340

322

View full text Add to dashboard Cite

show abstract

“…Conservative non-surgical therapy can result invariably in a fatal outcome from massive hemoptysis or chronic mediastinitis [4], and stent-graft insertion is safe and less invasive. However, there are limitations, and generally there is a higher risk of graft infection with repeated ABFs [4,5]. Here, we present patients with ABFs that have been successfully treated by removal of the aorta, concomitant resection of the lung, and coverage of the aorta using the pericardial membrane to prevent further erosive damage.…”

Section: Introductionmentioning

confidence: 99%

Effective strategy in the treatment of aortobronchial fistula with recurrent hemoptysis

Son

Lee

Kim

2020

Yeungnam Univ J Med

View full text Add to dashboard Cite

Aortobronchial fistula (ABF) involves the formation of an abnormal connection between the thoracic aorta and the central airways or the pulmonary parenchyma and is associated with an increased risk of mortality. An ABF typically manifests clinically with symptoms of hemoptysis, and currently, there is a lack of defined guidelines for its treatment. Here, we report the cases of two patients who suffered from recurrent hemoptysis due to ABF with pseudoaneurysm. We propose that removal of the aorta with concomitant lung resection and coverage of the aorta using the pericardial membrane is a definite treatment to lower recurrence of ABF and persistent infection.

show abstract

Die europäischen Leitlinien zur Versorgung von Gefäßprothesen- und Stentgraftinfektionen

2020

View full text Add to dashboard Cite

Thoracic Endovascular Aortic Repair for Aortobronchial Fistula

Cited by 41 publications

References 46 publications

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections

Effective strategy in the treatment of aortobronchial fistula with recurrent hemoptysis

Die europäischen Leitlinien zur Versorgung von Gefäßprothesen- und Stentgraftinfektionen

Contact Info

Product

Resources

About